Dendreon
Navigation Links
Dendreon in Medical News
GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN
... Generex Biotechnology, Corp. (Nasdaq: GNBT ), Cell Therapeutics, Inc. (Nasdaq: CTIC ), Cancer Therapeutics Inc. (OTC Bulletin Board: CTHP), & dendreon Corp. (Nasdaq: DNDN ). GlobalEquityReport.com alerts its members daily on stocks that are hot in the market. These include stocks with huge...Dendreon Corp. (Nasdaq: DNDN) - Prostate Cancer Patients Benefit
...lk section , posted a Special Technical Report on dendreon Corporation (Nasdaq: DNDN ), which we have been ...ge of 4.1 months. According to published analysts, dendreon should be able to file for regulatory approval dur...roval during the first half of 2010. This is dendreon Corp (DNDN):...Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008
...ode Debrabandere, PhD, Vice President & General Manager Inflammatory Diseases, Osiris * Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, dendreon Corporation * Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma * Milton H. Grannatt, PhD, Vice President and Head, Negotiation......ics for the treatment of cancer with technology licensed from Fred Hutchinson Cancer Research Center. From 2000 to 2005, Mr. Pickering was employed by dendreon Corporation in Seattle, Washington and served as a Corporate Officer and most recently as its Senior Vice President of Operations. During his tenure a...
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
...ce Committees of the Board of Directors. Mrs. Bayh currently serves on the boards of directors of Curis, Inc., a therapeutic drug development company, dendreon Corporation, a therapeutic drug development company, Dyax Corp., a biopharmaceutical company, Emmis Communications, a diversified media company, and W...-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET-
... SEATTLE, Nov. 2 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) will release its third ...g for 30 days at http://www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
...g companies based in San Francisco. The new hires include seasoned corporate communications and investor relations experts Monique Greer, formerly of dendreon Corporation, and Nicole Foderaro, formerly of Nuvelo, Inc. In addition, several other associates have joined its offices across the country, including...Dendreon in Medical Technology
...GO and SEATTLE, April 28 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that... and specifications outlined in its SPA agreement, dendreon intends to file an amendment to its existing Biolo...nference Call Scheduled for Today at 5:30 pm ET
dendreon will host a conference call today at 5:30 pm ET. T...
...pril 28 /PRNewswire-FirstCall/ -- Researchers from dendreon Corporation (Nasdaq: DNDN ) today presented prec...se and key role in cell biology and in pathology. dendreon has synthesized small molecule agonists including ...8 ion channel and induce cell death. About dendreon ...
... SEATTLE, April 13 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) will host a conferen...ing for 30 days at www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...
... SEATTLE, Nov. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) today will present a su...s a complete course of therapy. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
... SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) will host a conference ...s at http://www.dendreon.com . About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
... SEATTLE, July 16 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that ...al, combined with low toxicity. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
...pril 28 /PRNewswire-FirstCall/ -- Researchers from dendreon Corporation (Nasdaq: DNDN ) today presented prec...se and key role in cell biology and in pathology. dendreon has synthesized small molecule agonists including ...8 ion channel and induce cell death. About dendreon ...
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
... SEATTLE, April 21 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...se and key role in cell biology and in pathology. dendreon has synthesized small molecule agonists including ...8 ion channel and induce cell death. About dendreon ...CEL-SCI Corporation Releases Letter to Shareholders
...ortant event has just transpired for our company. dendreon Corporation has announced that its pivotal Phase I...ssible to be heard. The successful outcome of the dendreon study gives the cancer immunotherapy field the nee...to attract new money to the space. The success of dendreon proves that it is possible to harness the human im...... SEATTLE, April 13 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) will host a conferen...ing for 30 days at www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...
... SEATTLE, Nov. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) today will present a su...s a complete course of therapy. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
...oday - SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) announced today that it...ndent data monitoring committee (IDMC) reported to dendreon a 20 percent reduction in the risk of death in the...ed, metastatic prostate cancer. About Dendreon dendreon Corporation is a biotechnology company whose missi...... SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) will host a conference ...s at http://www.dendreon.com . About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
... SEATTLE, July 23 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that ...riterion for statistical significance be achieved, dendreon would anticipate amending its Biologics License Ap...ancer with a primary endpoint of overall survival. dendreon is conducting the IMPACT trial under a Special Pro...... SEATTLE, July 16 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that ...al, combined with low toxicity. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
Dendreon in Biological Technology
Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
... SEATTLE, July 30 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) management will host...or 30 days at www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...New Report Just Published: World Prostate Cancer Therapeutics Market Report
..., Bristol-Myers Squibb Company, Cell Genesys Inc., dendreon Corporation, EUSA Pharma, (USA) Inc., F. Hoffmann-...n with Seattle Genetics II-80 Diosynth and dendreon Sign Multi-Year Commercial Supply Deal II-80 G... Products to Treat Prostate Diseases II-84 dendreon Constructs Manufacturing Facility in New Jersey II...CEL-SCI Corporation Releases Letter to Shareholders
...n 12% of the patients after only a 3-week treatment. The recent success of dendreon with its prostate cancer vaccine has shown that it is possible to stimulate the immune system of cancer patients to increase survival. dendreon went from about $3 to $27 on that news. The validation of the manufacturin...Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
... SEATTLE, June 5 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...rom Dendreon's website, www.dendreon.com . dendreon Corporation is a biotechnology company whose missi...didates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...Biotech Shows Glimmer of an Upward Trend
...at they don't lose out to their competitors," added Burrill. Shares of dendreon have increased in value by a whopping 440 percent since the company first a...dvanced prostate cancer by an average of 4.1 months. According to analysts, dendreon should be able to file for regulatory approval during the fourth quarter 20...... SEATTLE, May 14 /PRNewswire-FirstCall/ -- dendreon Corporation today announced that Chief Executive O...Seattle Business and The Summit Group. About dendreon dendreon Corporation is a biotechnology company whose missi...
Dendreon Announces Closing of Common Stock Offering
... SEATTLE, May 13 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) announced today the ...gregate of 11,979,166 shares of common stock. dendreon received net proceeds from the offering of approxi...ting commissions and estimated offering expenses. dendreon plans to use the net proceeds of the offering to d...Dendreon Announces Common Stock Offering
... SEATTLE, May 8 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) announced today the ...rities will act as sole manager for the offering. dendreon has granted Deutsche Bank Securities an option t...mon stock to cover over-allotments, if any. dendreon intends to use the net proceeds of the offering to...Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
... SEATTLE, May 7 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...rom Dendreon's website, www.dendreon.com . dendreon Corporation is a biotechnology company whose missi...didates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...Dendreon Reports First Quarter 2009 Financial Results
... SEATTLE, May 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today reported resul...erence on May 20, 2009 About dendreon dendreon Corporation is a biotechnology company whose missi...Other TagsHailRSPIndoIndoIndoIndoIndoOther Contentsmutationalmutationalratchetratchetmusclemusclemusclemusclemusclemusclemusclemusclemusclemusclemutagenmyosinmyosinmyosindinucleotideadenineadenineadenineadenineadenine
(Date:11/27/2009)...irm Replikins Ltd. today issued its latest biochem...shows that the lethality of the virus has dropped ... current outbreak in the spring of 2009 to resting...The H1N1 infectivity count, however, remains incre...vember 27, 2009 -- Biotech firm Replikins Ltd., wh...
(Date:11/27/2009)...ance, Nov. 27 Team Garmin-Slipstre...edicated to ethical sporting and developing the ne...y that it will become Team Garmin-Transitions with...sor of the team. Transitions Optical is the world,...ng the most advanced photochromic technology in th...
(Date:11/27/2009)...d medical, economic burdens, study predicts , ...mber of people with diabetes in the United States ...w study predicts. , That would bring the total ...ase, up from 23.7 million today. , , At the same...ill triple, the study also warns, rising from an e...
(Date:11/27/2009)...t manufacturers who use medical load cells at the ...lars by bringing in technology partner Flintec ear...o-active medical manufacturers are calling in Flin...r projects, ensuring that progress will not be con...ly outdated technology. , ...
(Date:11/26/2009)...of Americans living with diabetes will nearly doub...illion in 2034. Over the same period, spending on ...ion to $336 billion, even with no increase in the ...iversity of Chicago report in the December issue o...abetes covered by Medicare will rise from 8.2 mill...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] Diabetes Cases Expected to Double in 25 Years[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[0] Diabetes cases to double and costs to triple by 2034
(Date:11/26/2009)...t worked out a way of using recordings of birdsong...s. This is the first time sound recordings from a ...e estimates of bird species, populations. Because ...cal Society,s Journal of Applied Ecology , will a... advance in our ability to monitor whale and dolph...
(Date:11/26/2009)...mber 26, 2009) Whitehead researchers have develop... pinpoint specific genes and proteins used by path...In most human cell cultures genes are present in t...rom the mother. Gene inactivation by mutation is t...tivated, the second copy usually remains active an...
(Date:11/26/2009)...stant Staphylococcus Aureus ) and other drug-resi...erature plasma prototype devices have been develop...icidal cocktails. , Two prototype devices have b...ealthy skin (e.g. hands and feet) in hospitals and...reat; and another to shoot bacteria-killing agents...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 1Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 2Farmers Insurance Annual Challenge 3A Be a Hero for Babies Day 28SM 29 50795 3The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 1The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 2The Leukemia 26 Lymphoma Society and The International Waldenstroms Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research 12902 3Dogs humans put heads together to find cure for brain cancer 9117 1Dogs humans put heads together to find cure for brain cancer 9117 2Dogs humans put heads together to find cure for brain cancer 9117 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |